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Background: Post-translational modification is an important approach to regulate NF-B activity.
Results: Serine 316 (Ser-316) is a novel phosphorylation site on p65.
Conclusion: Phosphorylation of Ser-316 on p65 is essential for NF-B activation and its related biological functions.
Significance:Our data shed light on how NF-B transcriptional specificity is achieved through site-specific phosphorylation.
Nuclear factorB (NF-B) is a central coordinator in immune
and inflammatory responses. Constitutive NF-B is often found
in some types of cancers, contributing to oncogenesis and tumor
progression. Therefore, knowing how NF-B is regulated is
important for its therapeutic control. Post-translational modi-
fication of the p65 subunit of NF-B is a well known approach
for its regulation.Here, we reported that in response to interleu-
kin 1, the p65 subunit ofNF-B is phosphorylated on the novel
serine 316. Overexpression of S316A (serine 316 3 alanine)
mutant exhibited significantly reduced ability to activateNF-B
and decreased cell growth as compared with wtp65 (wild type
p65). Moreover, conditioned media from cells expressing the
S316A-p65 mutant had a considerably lower ability to induce
NF-B than that of wtp65. Our data suggested that phosphory-
lation of p65 on Ser-316 controls the activity and function of
NF-B. Importantly,we found that phosphorylation at thenovel
Ser-316 site and other two known phosphorylation sites, Ser-
529 and Ser-536, either individually or cooperatively, regulated
distinct groups of NF-B-dependent genes, suggesting the
unique role of each individual phosphorylation site on NF-B-
dependent gene regulation. Our novel findings provide an
important piece of evidence regarding differential regulation of
NF-B-dependent genes through phosphorylation of different
p65 serine residues, thus shedding light on novel mechanisms
for the pathway-specific control of NF-B. This knowledge is
key to develop strategies for prevention and treatment of con-
stitutive NF-B-driven inflammatory diseases and cancers.
Transcription factor NF-B plays central roles in immune
and inflammatory responses and in oncogenesis and tumor
progression. NF-B family has five members that include: RelA
(p65), RelB, C-Rel, NF-B1 (p50), and NF-B2 (p52). The most
common NF-B prototype is the heterodimer of p65 and p50,
with p65 as the major subunit. All family members share an
N-terminal DNA binding region named Rel homology domain
(1). Under normal cellular conditions, NF-B localizes in cyto-
plasm as an inactive complex by binding to the inhibitor of
NF-B (IB).3 Upon treatment with different stimuli, NF-B is
activated through specific pathways. In general, activation of
NF-B can be classified into canonical and non-canonical path-
ways. The canonical NF-B activation pathway is well estab-
lished and includes the activation of an IB kinase complex
followed by the phosphorylation-induced degradation of IB.
This process enables the p65/p50 heterodimer to enter the
nucleus and activate the expression of specific NF-B target
genes (1). NF-B activity is known to be regulated by different
types of post-translational modifications, including phosphor-
ylation, ubiquitination, acetylation, sumoylation, nitrosylation,
and methylation, etc. (2–8), especially on its p65 subunit.
Phosphorylation is a type of post-translational modification
that universally exists in almost every process of the cell life
cycle. Protein kinases catalyze phosphorylation on serine, thre-
onine, or tyrosine residues by adding a covalently bound phos-
phate group (9). This process switches the protein states
between either active or inactive forms, leading to a change in
protein function or localization. Improper regulation of protein
phosphorylation is often related to many kinds of diseases,
including cancer. Thus, identification of novel phosphorylation
sites of a given protein is critical for the understanding of pro-
tein regulation in normal conditions as well as in disease states
(10, 11).
As the major subunit of NF-B, p65 has drawn great atten-
tion with respect to the nature of its post-translational modifi-
cations. To date, 12 phosphorylation sites have been identified
on p65 in response to different stimuli and/or in different cell
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systems. Among them, four sites (Ser-205, Thr-254, Ser-276,
Ser-281) are located in the N-terminal RHD, one site (Ser-311)
is in the linker region that is adjacent to the N-terminal RHD,
and seven residues (Thr-435, Ser-468, Thr-505, Ser-529, Ser-
535, Ser-536, and Ser-547) are contained in the C-terminal
transactivation domain (3, 12, 13). Most of these phosphoryla-
tion events positively modulate NF-B transcriptional activity.
For example, the catalytic subunit of PKA (PKAc) stays inactive
by binding to IB to form anNF-B-IB-PKAc complex. Extra-
cellular signals such as lipopolysaccharide, which degrade IB,
lead to activated PKAc to phosphorylate p65 on Ser-276 in
70Z/3 pre-B cells (14). This PKAc-mediated phosphorylated
p65 interacts with CBP/p300 to positively regulate the transac-
tivation potential of p65 (15). Interestingly, Ser-276 of p65 is
also reported to be phosphorylated by mitogen- and stress-ac-
tivated protein kinase-1 (MSK1) upon tumor necrosis factor 
(TNF)-mediated NF-B activation in mouse L929sA cells
(16). Haegeman and co-workers (16) found that Ser-276 is a
crucial residue for the regulation of the nuclear transactivation
capacity of p65. Therefore, Ser-276 phosphorylation is a pre-
requisite for the induction of NF-B-dependent genes (16).
These findings raised the possibility thatmultiple kinases could
target the same serine residue in different experiment systems.
Furthermore, Toriumi and co-workers (17) reported that IB
kinase phosphorylates the NF-B p65 subunit on serine 536,
leading to enhanced p65 transactivation in HeLa cells. More-
over, Baldwin and co-workers (18) found that TNF could
induce Ser-529 phosphorylation on p65, a process that is con-
trolled by casein kinase II. It is worth noting that, althoughmost
of the phosphorylation events lead to NF-B activation, there
are few instances in which phosphorylation on the same site
could either positively or negatively regulate NF-B activity
depending on the specific experimental systems. A relevant
example would be the phosphorylation of Ser-468. Ser-468 is
phosphorylated by IB kinase  leading to an enhanced p65
transcriptional activity in T-cells in response to T-cell co-stim-
ulation (19). On the other hand, Ser-468may also be phosphor-
ylated by GSK-3, exerting a negative regulatory effect on basal
NF-B activity inHeLa cells (20). This interesting phenomenon
clearly exemplifies the extremely complex biological conse-
quences caused by the phosphorylation of p65.
In this study, using mass spectrometry we identified the
novel phosphorylation of Ser-316 on p65 upon interleukin
1-induced NF-B activation. We showed that phosphoryla-
tion of Ser-316 regulates a distinctive group of NF-B-depen-
dent genes as comparedwith those of Ser-529 or Ser-536. Thus,
we suggest that novel phosphorylation of Ser-316 is critical for
NF-B-dependent differential gene regulation and leads to spe-
cific biological consequences. Our finding provides an impor-
tant piece of evidence regarding how the complicated NF-B
regulation is finely tuned and achieved.
Experimental Procedures
Cell Lines and Materials—The 293C6 cell line has been
described previously (21). Briefly, human 293C6 is a pool of
293IL1R cells (which carry transfected IL1 receptors and acces-
sory protein). Due to the overexpression of the IL1 receptor,
293C6 shows robust NF-B activation upon cytokine stimula-
tion like IL-1. Also 293C6 shows no constitutively active
NF-B and thus has normal levels of p65 (22).
Themouse embryo fibroblasts (MEF) cell line was a kind gift
from Dr. Alexander Hoffman (University of California at San
Diego) (23). Anti-phosphorylated Ser-529-p65 and phosphor-
ylated Ser-536-p65 antibodieswere fromCell Signaling, and the
anti-p65 antibody was from Santa Cruz Biotechnology. Anti--
actin was supplied by Sigma. Alexa Fluor 488 goat anti-mouse
IgGwas fromLife Technologies. Casein kinase I (CKI) inhibitor
D4476 was purchased from Sigma.
Site Mutagenesis of p65—Different p65 mutants (S316A,
S529A, S536A, S316A/S529A, S316A/S536A, S529A/S536A,
S316A/S529A/S536A) were generated by using QuikChange II
XL site-directed mutagenesis kit from Agilent Technologies
(24). Primers were designed using Agilent Technologies
QuikChange Primer Design online software.
Purification of Endogenous p65—293C6 cells were cultured
to95% confluence then were treated with 10 ng/ml IL-1 for
1 h. Cells were lysed, and endogenous p65 was immunoprecipi-
tated the same way as described before (23). The purified p65
band was excised and further subjected to mass spectrometry
analysis.
Digestion and Liquid Chromatography-Tandem Mass Spec-
trometric Analysis—The Coomassie-stained SDS-PAGE gel
band containing p65 protein was subjected to in-gel tryptic
digestion. First, p65 gel pieces were destained with 50% aceto-
nitrile in 100 mM ammonium bicarbonate followed by 100%
acetonitrile. Next, cysteine residues were reduced by incubat-
ing the sample with 20 mM DTT at room temperature for 60
min and alkylated with 55 mM iodoacetamide for 30 min in the
dark. The solution was removed, and the gel pieces were
washed with 100 mM ammonium bicarbonate and dehydrated
in acetonitrile. Gel pieces were then dried in a SpeedVac cen-
trifuge and rehydrated in 50 mM ammonium bicarbonate con-
taining sequencing grade modified trypsin (Promega, WI) for
overnight digestion at 37 °C. After proteolytic digestion, pep-
tides were extracted from the gel with 50% acetonitrile in 5%
formic acid, dried, and reconstituted in 0.1% formic acid for
mass spectrometry analysis.
Analysis of proteolytic digests was performed by using an
LTQ Orbitrap XL linear ion-trap mass spectrometer (Thermo
Fisher Scientific) coupled with an Ultimate 3000 HPLC system
(Dionex). The digests were injected onto a reverse-phase C18
column (0.075 150 mm, Dionex) equilibrated with 0.1% for-
mic acid, 4% acetonitrile (v/v). A linear gradient of acetonitrile
from 4 to 40% in water in the presence of 0.1% formic acid over
a period of 45 min was used at a flow rate of 300 nl/min. The
spectra were acquired by data-dependent methods, consisting
of a full scan (m/z 400–2,000) and then tandems on the five
most abundant precursor ions. The previously selected precur-
sor ions were scanned once during 30 s and then were excluded
for 30 s. The obtained data were analyzed by Mascot software
(Matrix Science) against customized p65 protein database with
the setting of 10 ppm for precursor ions and 0.8 Da for product
ions. Carbamidomethylation of cysteine was set as fixed modi-
fication, whereas oxidation ofmethionine and phosphorylation
of serine, threonine, and tyrosine were set as variable modifica-
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tions. The tandemmass spectra of candidate-modified peptides
were further interpreted manually.
Transfection and Luciferase Assay—Constructs were trans-
fected into cell lines by using the Lipofectamine and PLUS
Reagents (Invitrogen). To establish stable pools, cells were co-
transfected with a plasmid encoding a puromycin resistance
gene, and selected in 1 g/ml puromycin 48 h later. For NF-B
luciferase assays, the B-luciferase construct p5XIP10 B (23)
was transfected transiently into the cells, and luciferase activity
was quantified 48 h later. A -galactosidase construct was co-
transfected to normalize for transfection efficiency. Transfec-
tions and luciferase assays were carried out essentially as
described by Lu et al. (23).
Western Analysis—Cells cultured to 90–95% confluence
were treated with IL-1 at different time points. Samples were
collected and lysed by radio immunoprecipitation assay buffer
(150 mM NaCl, 0.1% Triton X-100, 0.5% sodium deoxycholate,
0.1% sodium dodecyl sulfate (SDS), 50 mM Tris-HCl, pH 8.0,
and protease inhibitors), and whole cell lysates were separated
by SDS/PAGE gels and further assayed by Western blotting
(23). Different antibodies were used to detect the target
proteins.
Immunofluorescence—Coverslips were coated with 0.1%
sterile gelatin for 2 h and dried for 30min at room temperature.
1  105 cells were then seeded onto coverslips per well in a
24-well plate. After overnight culture, cells were treated with
IL-1 for 1 h to continue with immunofluorescence experi-
ments. Cells were fixedwith 4% of formaldehyde for 30min and
then blocked with blocking buffer for 10 min at room temper-
ature. Coverslipswere further probedwith anti-FLAGantibody
and Alexa Fluor 488 goat anti-mouse IgG. Before sealing the
coverslips, mounting media with DAPI was used to stain the
nucleus. The slides were examined under Nikon Eclipse 80i.
Quantitative PCR Analyses—Cells cultured to 80–90% con-
fluence were transfected with different p65 constructs. RNA
samples were collected 48 h later. cDNA was generated using
reverse PCR. FastStart Universal SYBR Green Master ROX
(Roche Applied Science) was then used for the quantitative
PCR reactions. Primers were designed by Primer Express 3.0
software (8). Primers were: TRIM73 forward (5-TGAAGCA-
GGAGCAGAAGAAGGT-3) and reverse (5-TCCGACTCA-
TTGACGATTCG-3; TTLL2 forward (5-TCTTGAAGCCG-
CTGGTTTTT-3) and reverse (5-CCAGGAGGACGCTTT-
GCA-3); USP28 forward (5-AGAGACCCCCACCTCTC-
ACA-3) and reverse (5-TACCCTTTTGGGTGCTTCATTT-
3; NKG7 forward (5-CTTTGAGCACCGATTTCTGGTT-
3) and reverse (5-TGTCCCCATGCCCTGTTG-3; SLC32A1
forward (5-ATCTTCGCCGCCGTTGT-3) and reverse
(5-CCGTCTTCATTCTCCTCGTACAG-3).
Cell Growth Assay—Cells were plated at 2 104/well in trip-
licate per time point in 6-well plates. Cells were trypsinized,
resuspended, and counted using a cell counting chamber on
days 3, 5, 7, and 9 (23).
Illumina Microarray Analysis—250 ng of RNA was reverse-
transcribed into cRNA and labeled with biotin-UTP using the
Illumina TotalPrep RNA Amplification kit (Ambion/Applied
Biosystems). cRNA was quantified using a nanodrop spectro-
photometer, and the cRNA quality (size distribution) was fur-
ther analyzed on a 1% agarose gel. cRNA was hybridized to the
Illumina Human Ref-v3 v1Expression BeadChip and scanned
into a BeadArray Reader using standard protocols (provided by
Illumina). Illumina BeadStudio softwarewas used for data anal-
ysis (23).
Conditioned Media Assay—293C6 cells and MEFp65/
cells were seeded into 12-well plates and transfected with dif-
ferent plasmids: empty vector, wtp65, or S316A-p65. Twenty-
four hours after transfection, media in the cell culture plates
were replaced with fresh media, and cells were cultured for an
additional 48 h. Conditioned media were then collected and
used to treat stable 293-NF-B reporter cells for 4 h before
carrying out luciferase assay (23).
Human Cytokine ELISA Arrays—Human cytokine ELISA
arrayswere purchased fromSignosis. Experimentswere carried
out according to the manufacturer’s protocol. Briefly, condi-
tioned media collected from 293C6 control, wtp65, or S316A-
p65 stable cell lines were added to specific cytokine capture
antibody-precoated wells for 2 h at room temperature. After
incubation, the wells were washed to remove unbound labeled
antibodies. The plate was further detected with HRP lumines-
cent substrate. The level of expression for each specific cytokine
was directly proportional to the luminescence thatwas emitted.
Statistical Analysis—The associations between relative lucif-
erase activity and relative gene expression in different groups
were analyzed by Student’s t test. The data represent the
mean S.D. from three independent experiments. A p value
0.05 was considered to be statistically significant.
Results
Identification of Novel Phosphorylation of Ser-316 on p65 by
Mass Spectrometry Analysis—NF-B is known to be phosphor-
ylated on different sites in response to different stimuli. To date
more than a dozen different phosphorylated sites have been
reported. Under inflammation conditions or within certain
tumor microenvironments, secreted cytokines such as IL-1
are important factors to keep NF-B constitutively activated
(25). To determine whether p65 can be phosphorylated on
novel sites after IL-1 treatment, we treated 293C6 cells with
IL-1 for 1 h and further isolated endogenous p65 protein by
using anti-p65 antibody (8, 23). The purified p65 band was fur-
ther subjected to mass spectrometry analysis. An 80-kDa mass
shift was observed clearly on Ser-316 in the IL-1-treated but
not in the untreated samples, suggesting that p65 is phosphor-
ylated on Ser-316 upon IL-1 treatment (Fig. 1). This exciting
finding indicates that Ser-316 is a novel phosphorylation site
during the process of IL-1-triggered NF-B activation.
Effect of the S316A Mutation on NF-B Activity—To test
whether phosphorylation of Ser-316 is important for NF-B
activation, we generated S316A-p65 mutant and further
expressed it at a similar level to that of wtp65 in either 293C6
(Fig. 2A, left panel) or MEFp65/ cells (Fig. 2A, right panel).
The effect of S316A-p65 mutation on NF-B activity was fur-
ther determined by carrying out the B-specific luciferase
assay. As shown in Fig. 2B, overexpression of wtp65 signifi-
cantly activated NF-B, and it was similar to what we observed
previously (8). However, overexpression of the S316A-p65
mutant protein lost this ability in both 293C6 (Fig. 2B, left
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panel) and MEFp65/ cells (Fig. 2B, right panel), confirming
that phosphorylation of Ser-316 of p65 is critical for the activa-
tion of NF-B. We wondered whether the decrease of NF-B
activity in S316A-p65 overexpression cells was related to the
altered NF-B nuclear translocation. We carried out immuno-
fluorescence assays in 293C6, wtp65, or S316A-p65 cells (Fig.
2C). Because bothwtp65 and S316A-p65 are taggedwith FLAG,
anti-FLAG antibody was used to detect cellular localization of
the overexpressed wtp65 and S316A-p65 proteins (shown in
green). DAPI was used for nuclear staining. 293C6 cells (with-
out any FLAG tagged p65 protein) were used as negative con-
trol for the anti-FLAG antibody (black). Data suggested that
before IL-1 treatment of the wtp65 overexpressing cell line,
p65 was observed in both the cytoplasm and the nucleus but
mainly in the cytoplasm, confirming the well known phenom-
enon that overexpression of wtp65 leads to constitutive activa-
tion of NF-B. However, after IL-1 treatment, more p65 was
further translocated into the nucleus, suggesting that IL-1
could further induce NF-B activation. In contrast, S316A-p65
was largely distributed into the cytoplasm before or post IL-1
treatment, indicating that mutation at Ser-316 led to the defect
of nuclear translocation of the p65 subunit. In short, our data
support the notion that S316A-p65 mutant led to decreased
NF-B activity via compromised ability of NF-B nuclear
translocation.
Phosphorylation of p65 on Ser-316 Is Critical for NF-B-in-
ducible Gene Expression—Often a specific post-translational
modification site is associated with the regulation of some spe-
cific genes. To assess the role of Ser-316 in NF-B-inducible
gene expression, RNA samples from 293C6 cells with either the
overexpression of wtp65 or the S316A-p65 mutant protein
were used for the Illumina microarray assay. Our data sug-
gested that 72% of wtp65-inducible genes were down-regu-
lated by 2-fold ormore by the S316A-p65mutation, supporting
the notion that Ser-316 phosphorylation is important for the
activation of a majority of NF-B-inducible genes. A short list
of typical genes whose expression levels were affected by S316A
mutation is shown in Fig. 3A. These genes encode proteins
exhibiting a broad range of functions, such as chemokines,
important transcription factors, tumor promoting factors, etc.
We further carried out quantitative PCR to confirm the expres-
sion levels of several candidate genes. As shown in Fig. 3B, the
mRNA levels of tubulin tyrosine ligase-like family, member 2
(TTLL2), ubiquitin specific peptidase 28 (USP28), solute carrier
family 32A member 1 (SLC32A1), natural killer cell granule
protein 7 (NKG7), and tripartite motif containing 73 (TRIM73)
were strongly induced in cells with the overexpression of
wtp65, confirming that they are NF-B-inducible genes. In
great contrast, the expression levels of these genes were much
less induced by the overexpression of the S316A-p65 mutant
(Fig. 3B). Collectively, our Illumina microarray data demon-
strate the great importance of Ser-316 phosphorylation in the
induction of the majority of NF-B target genes.
Important Biological Effect of Ser-316 Phosphorylation—
Activation of NF-B is often associated with the induction and
release of multiple cytokines, chemokines, and growth factors.
We determined the effect of S316A mutation on the release of
cytokines and growth factors in both 293C6 and MEFp65/
cells. Conditioned media from cells with the overexpression of
either wtp65 or S316A-p65 mutant were collected and used to
treat stable 293-B reporter cells (8) for the NF-B-specific
luciferase assay. As shown in Fig. 4A, a significantly higher
FIGURE 1.Mass spectrometry identified Ser-316 phosphorylation of p65 in response to IL-1. Tandemmass spectrometry (ms2) of precursor ions in the
phosphorylated p65 peptide (amino acids 316–329; sequence SPFSGPTDPRPPPR, where S (red) indicates phosphorylated serine). Black lines indicate peptide
cleavage. Comparedwith unmodified 316–329 peptide, an 80-Damass shift was observed onprecursor ion andb series ions such as b3, b7, andb8, but not on
y series ions from y4 to y13, indicating phosphorylation of Ser-316.
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NF-B-inducing activity was observed from the media pro-
duced by wtp65 but not by S316A-p65 mutant-overexpressing
cells, confirming that S316A-p65 mutation greatly compro-
mised the expression and secretion of many NF-B activating
cytokines and growth factors.
To examine the secretory factor(s) regulated through phos-
phorylation of Ser-316 of p65, we carried out human cytokine
ELISA arrays in 293C6 control and wtp65 or S316A-p65 stable
cell lines (Fig. 4B). Data suggested that as compared with con-
trol group, 19 of 32 tested cytokines/chemokines have signifi-
cant induction in wtp65-overexpressing cells, suggesting these
cytokines/chemokines are NF-B-inducible factors. Impres-
sively, overexpression of S316A-p65 showed remarkably
reduced expression of most of these factors in comparison to
the media from wt-p65-overexpressing cells, supporting the
notion that phosphorylation of Ser-316 of p65 specifically con-
trols the secretion of a subgroup of cytokine/chemokines or
growth factors. Among these factors, especially TNF, inter-
feron -induced protein 10 (IP-10), regulated on activation
(normalT-cell expressed and secreted (Rantes)), vascular endo-
thelial growth factor (VEGF), monocyte chemotactic protein 1
(MCP1), and IL-8, -10, -17a, etc. showedmore dramatic effects
than other factors. Interestingly, these factors are often shown
to play important roles in inflammation, cell growth, and tumor
microenvironment, confirming the important role of Ser-316
phosphorylation in the regulation of NF-B activity.
Because cytokines, especially growth factors, could affect cell
growth, we further determined the effect of S316A-p65mutant
on cell growth. Stable pools of 293C6 cells with either overex-
pression of vector control, wtp65, or S316A-p65 mutant were
set up for this purpose (Fig. 4C, top panel). In comparison to
control cells, overexpression of wtp65 had considerably higher
cell numbers on the indicated days. Increased cell growth rate
was observed as early as day 3. However, no statistically signif-
FIGURE 2.Effects of theS316AmutationonNF-Bactivity.A,Western assays showing theoverexpressionofwtp65 and S316A-p65 in 293C6 cells (left panel)
or in MEFp65/ cells (right panel). The molecular marker is marked on the left. Units are in kDa. B, luciferase assay of NF-B activity. Overexpression of wtp65
significantly activated NF-B, whereas overexpression of the S316A-p65 mutant protein reduced this activity in both 293C6 cells (left panel) and MEFp65/
cells (right panel). Results of triplicate luciferase assays are shown as the mean  S.D. *, p  0.01 versus control (Ctrl) group; #, p  0.01 versus wt group. C,
immunofluorescence, showing the localization of wtp65 and S316A-p65. Both FLAG-tagged wtp65 and S316A-p65 were probed with anti-FLAG antibody.
DAPI was used for nuclear staining. In thewtp65 overexpression cell line, without IL-1 treatment the localization of p65was observed in both cytoplasm and
nucleus but mainly in the cytoplasm; however, after IL-1 treatment, p65 was largely translocated into the nucleus. In contrast, p65 translocation was
substantially decreased in cell lines with S316Amutation in the presence or absence of IL-1 treatment, indicating thatmutation at Ser-316 compromised the
nuclear translocation of p65 subunit. Control 293C6 cell lines without overexpression of FLAG-tagged p65 did not show the expression of FLAG-tagged p65
and was used as a negative control.
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icant difference was observed for the cell growth rates between
the control and the S316A-p65 mutant groups (Fig. 4C, bottom
panel). Taken together, these interesting data strongly support
the critical role that Ser-316 phosphorylation plays in NF-B-
dependent biological functions.
Phosphorylation of Multiple Serine Residues Triggered by
IL-1—Among the 12 phosphorylated amino acids that were
reported, two (Ser-529 and Ser-536) are frequently observed
and well known. In 1998, Ser-529 phosphorylation was first
identified in HeLa cells under the treatment of TNF (26). A
year later, Ser-536 phosphorylation was also discovered in
TNF-treated HeLa cells (17), suggesting that the same cyto-
kine could induce the phosphorylation ofmore than one amino
acid residue.We had not previously tested the phosphorylation
of either Ser-529 or Ser-536 in response to IL-1 in our 293C6
cell system. In the same p65 sample from which Ser-316 phos-
phorylation was identified, we observed the phosphorylation of
Ser-529 and Ser-536. To further confirm the phosphorylation
of Ser-529 and 536 of p65 and to analyze their induction kinet-
ics in 293C6 cells upon IL-1 treatment, we treated 293C6with
IL-1 for indicated times and directly used p65 site-specific
phosphorylation antibodies to examine the phosphorylation
status of Ser-529 and Ser-536 byWestern analysis. As shown in
Fig. 5, both Ser-529 and Ser-536 are dramatically phosphorylat-
FIGURE 3. Regulation of NF-B-dependent gene expression by Ser-316 phosphorylation. A, a short list of NF-B-dependent genes that are down-
regulated by S316A-p65 mutant. These genes encode proteins that have a broad range of functions. B, quantitative PCR analysis showing that TTLL2, USP28,
SLC32A1,NKG7, and TRIM73were inducedby theoverexpressionofwtp65 as comparedwith control cells. However, this inductionwasgreatly decreased after
S316A-p65 mutation. The data represent the mean S.D. from three independent experiments. *, p 0.01 versus control (Ctrl) group; #, p 0.01 versus wt
group.
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ed in a dynamic pattern after the treatment of IL-1 (Fig. 5, top
two panels). Both Ser(P)-529-p65 and Ser(P)-536-p65 started to
show up at 15 min or an earlier time point and reached the
peak at 30 min then gradually started to decay at 2 h after
the treatment of IL-1. This interesting phenomenon proved
that, in response to one of the most important cytokines in
human system, i.e. IL-1, p65 could be phosphorylated not only
on Ser-316 but also on Ser-529 and Ser-536. Furthermore, our
data clearly pointed out that IL-1-induced IB degradation
is an important step in the activation of NF-B (Fig. 5, third
panel), and phosphorylation of both Ser-529 and Ser-536 hap-
pens before IB degradation even occurs.
Role of Serine Phosphorylation in Differential Gene Regu-
lation—It is quite interesting to observe that p65 is phosphor-
ylated on different serine residues in response to the same cyto-
kine. We hypothesize that phosphorylation of each individual
serine is responsible for the regulation of different subgroups of
B-inducible genes. To test this hypothesis, we generated Ser-
316, Ser-529, and Ser-536 single, double, and triple alanine
mutants. 293C6 cells overexpressed with wtp65 or different
S-A-p65 mutants were used to carry out a thorough Illumina
microarray assay to compare the gene induction profiles of
these phosphorylation sites. As shown in Fig. 6A, in comparison
to wtp65 cells, each single site mutant down-regulated (by
2-fold or more)7080% of NF-B target genes with S316A-
p65 affected 72% (603 genes), S529A affected 80% (663
genes), and S536A affected 80% (668 genes) of NF-B target
genes, respectively. Surprisingly, double or triple mutants only
moderately increased the number of genes that are down-reg-
ulated as compared with those of different single mutants.
Overall, different double mutants reduced the expression of
85%ofNF-B target genes (by 2-fold ormore). In comparison
to wtp65 cells, cells that expressed S316A/S529A double
mutant reduced83% (by 2-fold or more) (690 genes), S316A/
S536A reduced 84% (702 genes), and S529A/S536A reduced
86% (720 genes) of NF-B target gene expression. Further-
FIGURE 4. Important biological functions of Ser-316. A, assays of conditioned media showing that conditioned media from 293C6 cells (left panel) overex-
pressing wtp65 had much higher NF-B-inducing activity than media from cells overexpressing the S316A-p65 mutant protein. Similar phenomenon was
observedwithMEFp65/ cells (right panel). Stable 293-NF-B reporter cells were used. The data were normalized to the total number of cells that generated
the conditionedmedia and to the total amountsofprotein. The results of triplicate luciferase assays are shownas themeanS.D. *,p0.05 versus control (Ctrl)
group; #, p  0.05 versus wt group. B, analysis of cytokine expression in the conditioned media from 293C6 control, wtp65, or S316A-p65 by using human
cytokine ELISA plate array. Total 32 cytokines/chemokines were tested. C, cell growth rate assay. Top panel, Western assays showing overexpression of wtp65
and Ser-316-p65 in 293C6 stable cells. The molecular marker is marked on the left. Units, kDa. Bottom panels: cell growth rate, showing that wtp65-overex-
pressing cells grew much more rapidly than either control or S316A-p65-overexpressing cells. The results of triplicate luciferase assays are shown as the
mean S.D. *, p 0.05 versus control group.
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more, S316A/S529A/S536A triple mutant down-regulated the
expression of86% (720 genes) of NF-B target genes, which is
not much different from those of double mutants, suggesting
that there are rarely genes co-regulated by all three serine resi-
dues together. Detailed comparisons of genes that are affected
by one, two, or three different serine residues are shown in Fig.
6, B–E. Particularly, as indicated in Fig. 6, D and E, phosphory-
lation of Ser-316, Ser-529, and Ser-536 can either share the
regulation of someNF-B-dependent genes or solely regulate a
subgroup of genes. For example, Ser-316, Ser-529, and Ser-536
solely regulated 19, 37, or 31 genes, respectively. In contrast,
Ser-316, Ser-529, and Ser-536 share the regulation of most of
the genes at different regulation levels. For example, Ser-316
and Ser-529 share the regulation of 522 NF-B target genes,
whichmeans these 522 genes can either be regulated by Ser-316
alone or by Ser-529 alone. Among these 522 genes, the third
residue, Ser-536, cannot regulate 51 genes (Fig. 6, D and E).
Likewise, Ser-316 and Ser-536 share the regulation of 533 com-
mon genes; among them, the third residue Ser-529 cannot reg-
ulate 62 genes. Ser-529 and Ser-536 share the regulation of 575
NF-B target genes; 104 of them cannot be regulated by Ser-
316. Finally, the majority of NF-B target genes (471 genes)
can be regulated by any of these three residues. This phenom-
enon supports a hierarchical regulation pattern for serine-de-
pendent differential gene regulation.
CKI Phosphorylates p65 at Ser-316—To determine which
kinase(s) phosphorylates p65 at Ser-316, we carried out a mass
spectrometry protein identification experiment to identify the
kinases that can bind to p65 in response to IL-1 treatment.
Casein kinase I was identified as a top candidate. We further
used the Human Protein Reference Database to predict poten-
tial kinases that related Ser-316 phosphorylation (27). Once
again, CKI was identified as the top candidate. We then used
the CKI-specific inhibitor D4476 to determinewhether it could
block IL-1-induced p65 phosphorylation. D4476 is a cell-per-
meable triaryl substituted imidazolo compound that acts as a
selective inhibitor of CKI. 293C6, wtp65, and S316A-p65 cells
were treated with 50 M D4476 for 4 h, and samples were then
collected for the luciferase assay. As shown in Fig. 7, D4476
dramatically decreased NF-B activity in both IL-1-induced
293C6 control cells and wtp65 overexpressing cells. In great
contrast, D4475 barely had any effect on the NF-B activity in
S316A-p65-overexpressing cells. These data strongly suggested
that CKI phosphorylated Ser-316 of p65.
Hypothetical Model—Based on our current study, we pro-
pose the following. 1) Ser-316 is a novel phosphorylation site
after the treatment of IL-1. 2) Multiple serine residues can be
phosphorylated by the same activating stimulus, such as IL-1.
3) S316A mutation affects p65 nuclear translocation. 4) Phos-
phorylation of different serine residues leads to the activation of
different subgroups of NF-B target genes. 5) The majority of
NF-B target genes can be regulated by any of the three serine
residues we studied; therefore, if one residue loses its function,
it will affect the expression of the majority of NF-B target
genes. 6) The purpose of multiple serine regulation is to fine-
tune the regulation of NF-B genes, adding more derivative
functions to the original NF-B core function. 7) CKI is the
kinase that phosphorylated p65 at Ser-316 site (Fig. 8).
Discussion
Although phosphorylation is the very original type of modi-
fication identified on p65, its role inNF-B regulation is still not
fully understood. Why do cells need to phosphorylate multiple
serine residues on p65? How do different sites of serine phos-
phorylation contribute to NF-B gene regulation? These inter-
esting phenomena motivated us to further explore whether
there are any unidentified serine phosphorylations on p65
beyond the existing knowledge.
In this study we discovered that Ser-316 was dramatically
phosphorylated upon the treatment of IL-1. We showed that
phosphorylation of Ser-316 enhanced p65 transcription activ-
ity. B-specific luciferase assay proved that overexpressing
wtp65 but not the S316A-p65 mutant significantly activated
NF-B in both 293C6 cells and MEFp65/cells. S316A-p65
mutant compromised p65 nuclear translocation, leading to the
loss of NF-B activation. Because many of NF-B target genes
are cytokines, chemokines, and growth factors, we further
tested the effect of Ser-316 mutation on the secretion of these
factors. Conditioned media from 293C6 cells overexpressing
either wtp65 or the S316A-p65 mutant were used to treat
NF-B reporter cells. Media from cells with the S316A mutant
protein decreased NF-B-inducing activity significantly more
than that from wtp65 cells. Similar results were obtained in
p65-null MEFs with the expression of either wt or the S316A-
p65mutant p65 (Fig. 4A), supporting that Ser-316 is important
for the secretion of many NF-B stimulating factors. By using
human cytokine ELISA arrays we identified Ser-316-specific
cytokines/chemokines such as TNF, IP-10, Rantes, VEGF,
MCP-1, IL8, IL-10, and IL17a, etc. that are critical for the pro-
cess of inflammation, cell growth, angiogenesis, and tumor
microenvironment. For instance, VEGF promotes endothelial
cell proliferation and migration in vitro (28). Inflammatory
mediators have a significant effect on the process of angiogen-
esis and tumor growth, mainly through up-regulation of VEGF.
Therefore, VEGF has been a therapeutic target for multiple
types of cancers (29, 30). Moreover, we further determined the
FIGURE 5. Dynamic phosphorylation of Ser-529 and Ser-536 of p65 in
response to IL-1 in 293C6 cells. A Western assay shows that upon IL-1
treatment, both Ser(P)-529 and Ser(P)-536-p65 were induced within 15 min
then started to decay after 2 h. Meanwhile, IB was degraded, indicating the
activation of NF-B. The molecular marker is marked on the left. Units, kDa.
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effect of Ser-316 on cell growth. Cell proliferation assays
showed that overexpression of wtp65 increased cell growth
rate, whereas no significant difference between control and
S316Amutantwas observed. Taken together, these data further
support the notion that phosphorylation of S316A is crucial for
the regulation of NF-B related biological functions.
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In addition to Ser-316 phosphorylation, it is interesting that
we found both Ser-529 and Ser-536 could also be phosphory-
lated under the same experimental conditions. The co-exist-
ence of three different serine phosphorylations on p65 raises a
very interesting question, i.e. are these phosphorylation sites
functionally unique or redundant? By generating a group of
single, double, or triple mutants of Ser-316, -529, and -536 sites
and examining their function in gene regulation, we show that
phosphorylation of each individual serine not only can control
the majority of NF-B targeted genes, which are commonly
shared with other two phosphorylation sites, but also can con-
trol its own subgroup of unique signature genes. Based on our
data, it is fair to say that the existence of each unique phosphor-
ylation site has its own function. Each phosphorylation site can
regulate the commoncore (80%, in our study) ofNF-B target
genes. Therefore, logically, if any phosphorylation site fails to
function properly, the entire commonly shared core gene pop-
ulationwill be affected. This is possibly a smart system that cells
have adopted for the regulation of NF-B. By doing so each
phosphorylation can not only support the basic regulation of
NF-B target genes expression but can also further fine-tune
NF-B-dependent gene expression to achieve both the flexibil-
ity and specificity in response to a given cellular stimulus or
under a specific cell system and cellular environment.
Importantly, we identified CKI as the kinase to phosphory-
late Ser-316 on p65. CKI belongs to the CK serine/threonine
kinase family. It is ubiquitously expressed in eukaryotic
organisms and highly conserved from yeast to human. The
CKI kinase has been shown to play an important role in
cancer development and is considered an important cancer
therapeutic target (31). CKI is involved in different but
rather important cellular functions such as regulation of
membrane transport, cell division, DNA repair, circadian
rhythms, and nuclear localization by phosphorylating its tar-
get proteins (32). Therefore, identification of CKI as the
kinase to phosphorylate Ser-316 of p65 added another sig-
nificant and interesting function to CKI.
In the future there is a great deal of work that needs to be
done. For example, although both Ser-529 and Ser-536 were
reported to be phosphorylated, the number and nature of the
kinases that catalyze these phosphorylation events are very
complex. There are multiple reports regarding the kinases that
phosphorylate Ser-529 or Ser-536, including IB kinase (, ,
and ), TRAF (TNF receptor-associated factor) familymember-
associated (TANK)-binding kinase 1 (TBK1)), PI3 kinase, p38
mitogen-activated protein kinase, and CKII (18) (33, 34). The
existing information certainly suggests that a number of kinases
may have the ability to phosphorylate the same serine residue
under specific conditions. Adding the CKI we identified in this
study, the combination of kinase and the residues that are phos-
phorylated possibly allows for a different group of genes to be
activated/repressed and is surely a fascinating research field to
further pursue.
Furthermore, it is worth noting an interesting phenomenon
regarding the distribution of phosphorylation on p65. Among
the 12 known phosphorylation sites, 4 are located in RHD
domain, 7 are located on the transactivation domain, and
only one site, the Ser-311, is located in the linker region of
p65 (35). Ser-311 is phosphorylated by the atypical protein
kinase C (PKC). Ser-311 phosphorylation is required for
CBP-enhanced NF-B transcriptional activity in embryo
fibroblasts in response to TNF stimulation. Our current
study identified a novel Ser-316 phosphorylation site in the
p65 linker region. Thus, it would be interesting to investigate
whether location of the phosphorylated site has any func-
tional effect on NF-B and correlates with induction of spe-
cific gene families.
In this paper we have discussed the phosphorylation sites in
domains of the p65 subunit, which is specifically involved in
activation of the canonical arm of the NF-B pathway. How-
ever, as mentioned before, few phosphorylation sites are also
located in the RHD domain, which is conserved in all the
family members of the NF-B superfamily. In this regard
another aspect to investigate would be to see if phosphory-
lation of sites in the conserved RHD domain affects the activ-
ity of the NF-Bmembers involved in the non-canonical arm
of the NFB signaling pathway. The non-canonical pathway
has distinct factors involved in comparison to the canonical
arm, and hence it would be interesting to see if there is cross-
regulation between these pathways linked by phosphoryla-
FIGURE 6. Differential regulation of NF-B-dependent genes by phosphorylation of Ser-316, -529, and -536. A–C, microarray data show the different
gene regulation effects by different p65 serine to alanine mutants, including S316A, S529A and S536A single mutants and S316/529, S316/536, S529/536
doublemutants as well as the S316A/S529A/S536A triplemutant. In this experiment, the data showing the ratio of gene expression levels frommutant(s) p65
versuswtp65, the levels of gene expression fromwtp65 sample were considered as 1. Overall, each singlemutant was able to decrease 7080% that of NF-B
target geneexpression.Double and triplemutants had slightlymoredramatic effect thaneach single sitemutant.D and E, phosphorylationof Ser-316, Ser-529,
and Ser-536 can either commonly (all three sites) regulate some of NF-B target genes or solely regulate their specific pools of genes. Moreover, two different
sites, i.e. Ser-316/529, or Ser-316/536 or Ser-529/536 can commonly regulate some genes, which are not regulated by the third S site, suggesting a hieratical
regulation pattern.
FIGURE 7. CKI Phosphorylates p65 at Ser-316. A, HPRD website predicted
CKI motif in position 316–319 of p65. B, NF-B activity was determined by
luciferase assay, showing that CKI inhibitor D4476 significantly decreased the
NF-B-inducing activity in both 293C6 cells treated with IL-1 and wtp65
overexpressing cells but had no notable effect on the S316A-p65 overex-
pressing cells, suggesting that D4476 functioned through Ser-316 phosphor-
ylation. The data represent the mean S.D. from three independent experi-
ments. *, p 0.01 versus controlIL-1 (CtrlIL-1) group; #, p 0.01 versus
wtp65 group.
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tion of the conserved sites of RHD domain and how that may
affect cell function.
In summary, our study identified Ser-316 as a novel IL-1-
inducible phosphorylation site on p65. We showed that
phosphorylation of Ser-316 is critical for NF-B nuclear trans-
location, NF-B-dependent gene regulation, cytokines/chemo-
kines secretion, and biological functions. Furthermore, we pro-
vided evidence of the co-existence of Ser-529 and Ser-536
phosphorylation on p65. Our microarray data strongly support
our hypothetical model that phosphorylation of different ser-
ine residues regulate the same common core (in our study,
80%) of NF-B target genes. On top of this basic function,
each individual phosphorylated serine residue exhibits its
own uniqueness for gene regulation, adding multiple facets
and layers of complexity to NF-B regulation. This strategy
for serine regulation may well exist in other types of post-
translational modifications of NF-B, such as ubiquitina-
tion, acetylation, and methylation, etc. Our study and
hypothesis further justify the necessity and strategy of tar-
geting specific protein kinases or other types of post-trans-
lation modification-mediating enzymes as specific and
effective ways to control excessive NF-B activity in NF-B-
driven inflammatory diseases and cancers. This pathway and
post-translational modification site-specific inhibition of NF-
B is impossible to achieve by simply targeting NF-B tran-
scription factor itself.
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